Richard A. Paulson - 04 May 2022 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
President and CEO, Director
Signature
/s/ Nancy Smith as Attorney-in-Fact for Richard Paulson
Issuer symbol
KPTI
Transactions as of
04 May 2022
Net transactions value
-$177,509
Form type
4
Filing time
05 May 2022, 16:08:07 UTC
Previous filing
02 Mar 2022
Next filing
08 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale $3,963 -633 -0.1% $6.26 661,317 04 May 2022 Direct F1
transaction KPTI Common Stock Sale $173,546 -27,869 -4.2% $6.23 633,448 04 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.